Sentinel node in breast cancer procedural guidelines

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 12, 2007, Pages 2154-2159

  Buscombe, John ^a   Paganelli, Giovanni ^b   Burak, Zeynep E ^c   Waddington, Wendy ^d   Maublant, Jean ^e   Prats, Enrique ^f   Palmedo, Holger ^g   Schillaci, Orazio ^h   Maffioli, Lorenzo ⁱ   Lassmann, M ^j   Chiesa, Carlo ^k   Bombardieri, Emilio ^k   Chiti, Arturo ^l  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e CENTRE JEAN PERRIN   (France)

^f HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^g UNIVERSITY OF BONN   (Germany)

^h TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

ⁱ Ospedale Civile di Legnano   (Italy)

^j UNIVERSITY OF WÜRZBURG   (Germany)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

more..

Author keywords

Axillary metastases; Breast cancer; Guidelines; Lymphoscintigraphy; Sentinel node

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; COLLOID TC 99M; PERTECHNETIC ACID TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M;

AUSTRALIA; BREAST CANCER; CANADA; CANCER DIAGNOSIS; COLLIMATOR; COLLOID; DOSIMETRY; EUROPE; HUMAN; INJECTION SITE; LYMPHOSCINTIGRAPHY; PRACTICE GUIDELINE; REVIEW; SCINTILLATION CAMERA; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

BREAST NEOPLASMS; HUMANS; ITALY; LYMPH NODES; LYMPHATIC METASTASIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RADIONUCLIDE IMAGING;

EID: 36749080875     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0614-z     Document Type: Review

References (30)

1. Keshtgar MRS, Ell PJ. Sentinel lymph node detection and imaging. Eur J Nucl Med 1999;26:57-67.
2. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
3. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 2006;7:983-90.
4. De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 39:2080-4.
5. Amersi F, Hansen NM. The benefits and limitations of sentinel lymph node biopsy. Curr Treat Options Oncol 2006;7:141-51.
6. Keleher A, Wendt R 3rd, Delpassand E, Stachowiak AM, Kuerer HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulphur colloid. Breast J 2004;10:492-5.
7. Morita ET, Chang J, Leong SP. Principles and controversies in lymphoscintigraphy with emphasis on breast cancer. Surg Clin North Am 2000;80:1721-39.
8. Gentilini O, Cremonesi M, Trifirò G, Ferrari M, Baio SM, Caracciolo M, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-51.
9. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer-a multi-center validation study. N Engl J Med 1998;339:941-6.
10. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
11. NEMA. NU 1 2001 Performance Measurements of Scintillation Cameras. Rosslyn: National Electrotechnical Manufacturers Association; 2001 ( http://www.nema.org/stds/nu1.cfm ).
12. IEC. IEC/TR 61948-2 Ed. 1.0 en:2001 Nuclear medicine instrumentation - routine tests - part 2: scintillation cameras and single photon emission computed tomography imaging. Geneva: International Electrotechnical Commission; 2001.
13. NEMA. NU 3 2004 Performance measurements and quality control guidelines for non-imaging intraoperative gamma probes. Rosslyn: National Electrotechnical Manufacturers Association; 2004 ( http://www.nema.org/stds/nu3.cfm ).
14. Mariani G, Moresco I, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001;42:1198-215.
15. Bourgeois P. Scintigraphic investigations of the lymphatic system: the influence of injected volume and quantity of labeled colloidal tracer. J Nucl Med 2007;48:693-5.
16. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer patients with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
17. Law M, Cheng KC, Wu PM, Ho WY, Chow LW. Patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a study using a female humanoid phantom and thermoluminescent dosimeters. Br J Radiol 2003;76:818-23.
18. Waddington WA, Keshtgar MRS, Taylor I, Lakhani SR, Short MD, Ell PJ. Radiation safety of the sentinel node technique in breast cancer. Eur J Nucl Med 2000;27:377-91.
19. Cremonesi M, Ferrari M, Sacco E, Rossi A, De Cicco C, Leonardi L, et al. Radiation protection in radioguided surgery of breast cancer. Nucl Med Commun 1999;20:919-24.
20. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloid albumin in breast cancer. J Nucl Med 1997;38:366-8.
21. Pelosi E, Bello M, Griors M, Ala A, Giani R, Bussone R, et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med 2004;45:220-5.
22. Chakera AH, Friis E, Hesse U, Al-Suliman N, Zerahn B, Hesse B. Factors of importance for scintigraphic non-visualization of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005;32:286-93.
23. Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med 2000;1:33-48.
24. International Electrotechnical Commission. Medical electrical equipment-part 1: general requirements for safety. IEC 60101-1. (1988-12). Geneva: IEC; 1988.
25. Paganelli G, Galimberti V, Trifirò G, Travaini L, De Cicco C, Mazzarol G, et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med 2002;46:138-44.
26. Clarke D, Khoni N, Mansel ER. Sentinel node biopsy in breast cancer. ALMANAC trial. World J Surg 2001;25:819-22.
27. Luini A, Galimberti V, Gatti G, Arnone P, Vento AR, Trifiro G, et al. The sentinel node biopsy after previous breast surgery; preliminary results on 543 patients treated at EIO. Breast Cancer Res Treat 2005;89:159-63.
28. Schwartz GF, Meltzer AJ. Accuracy of sentinel node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 2003;9:374-9.
29. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, et al. Retrospective analysis of sentinel node localization in multifocal multicentric, palpable, or non palpable breast cancer. J Nucl Med 2003;44:7-10.
30. Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Postlberger S, et al. Multicentric breast cancer: a new indication for sentinel node biopsy-a multi institutional validation study. J Clin Oncol 2006;24:3374-80.